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The cJun N-terminal kinase 1 (JNK1) is implicated in diet-induced obesity. Indeed, germline ablation of the
murine Jnk1 gene prevents diet-induced obesity. Here we demonstrate that selective deficiency of JNK1 in the
murine nervous system is sufficient to suppress diet-induced obesity. The failure to increase body mass is
mediated, in part, by increased energy expenditure that is associated with activation of the hypothalamic–
pituitary–thyroid axis. Disruption of thyroid hormone function prevents the effects of nervous system JNK1
deficiency on body mass. These data demonstrate that the hypothalamic–pituitary–thyroid axis represents an
important target of metabolic signaling by JNK1.
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Human obesity represents a serious world-wide health
problem. One consequence of obesity is the development
of insulin resistance, hyperglycemia, and metabolic syn-
drome that can lead to b-cell dysfunction and type 2
diabetes (Kahn et al. 2006). It is therefore important that
we gain an understanding of the physiology and patho-
physiology of the development of obesity, because this
knowledge represents a basis for the design of potential
therapeutic interventions.
The cJun N-terminal kinase 1 (JNK1) represents one
signaling pathway that has been implicated in diet-
induced obesity (Weston and Davis 2007). JNK1 is acti-
vated when mice are fed a high-fat diet (HFD) (Hirosumi
et al. 2002). Moreover, Jnk1/ mice are protected
against HFD-induced weight gain (Hirosumi et al. 2002).
The mechanism that accounts for the effect of germline
JNK1 deficiency to control body weight is unclear.
Tissue-specific deficiency of JNK1 in fat, muscle, liver,
and myeloid cells does not affect HFD-induced weight
gain (Sabio et al. 2008, 2009, 2010). A different organmust
therefore play a major role in the diet-induced regula-
tion of body weight by JNK1. The brain represents a pos-
sible site of JNK1 function because the hypothalamus
and pituitary gland are known to regulate metabolism, in-
cluding feeding behavior, physical activity, and energy
expenditure (Lenard and Berthoud 2008).
The purpose of this study was to investigate the role of
JNK1 in the brain. Our approach was to examine the
effect of selective ablation of the Jnk1 gene in the mouse
nervous system. We found that HFD-fed control (NWT)
mice gained substantially greater body weight than JNK1-
deficient (NKO) mice. The decreased weight gain by NKO
mice was accounted for by decreased food intake, in-
creased physical activity, and increased energy expendi-
ture. These changes were associated with increased
amounts of thyroid hormone in the blood and increased
expression of thyroid hormone-responsive genes in target
tissues. Importantly, pharmacological inhibition of thyroid
hormone markedly attenuated NKO phenotypes. These
data demonstrate that the hypothalamic–pituitary–thyroid
axis is a major target of the JNK1 signaling pathway that
regulates metabolism.
Results
To investigate the role of JNK1 in the nervous system, we
created compound mutant mice (Nestin-cre Jnk1LoxP/LoxP)
with a selective defect in the expression of JNK1. Geno-
type analysis of NWTand NKOmice demonstrated that the
5Present address: Departamento de Inmunologı´a y Oncologı´a, Centro
Nacional de Biotecnologı´a, CSIC Campus de Cantoblanco-UAM, 28049
Madrid, Spain.
6Corresponding author.
E-MAIL roger.davis@umassmed.edu; FAX (508) 856-3210.
Article published online ahead of print. Article and publication date are
online at http://www.genesdev.org/cgi/doi/10.1101/gad.1878510.
256 GENES & DEVELOPMENT 24:256–264  2010 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/10; www.genesdev.org
 Cold Spring Harbor Laboratory Press on June 1, 2016 - Published by genesdev.cshlp.orgDownloaded from 
Jnk1LoxP allele was efficiently deleted in the nervous
system of NKO mice (Fig. 1A). Thus, the Jnk1 gene was
ablated in all regions of the CNS of NKO mice that we ex-
amined, including the cortex, cerebellum, hypothalamus,
hippocampus, and medulla oblongata (Fig. 1A). Immuno-
blot analysis demonstrated markedly reduced JNK1 protein
in these subregions of the brain and normal amounts of
JNK1 in liver, muscle, and adipose tissue (Fig. 1B). Control
studies demonstrated that the Jnk1 gene was not deleted in
b cells of the Islets of Langerhans in NKO mice (Supple-
mental Fig. S1). These data indicate that NKO mice exhibit
a tissue-specific defect in JNK1 expression. NKOmice there-
fore represent a model for the analysis of nervous system-
specific JNK1 deficiency.
Nervous system JNK1 is required for HFD-induced
weight gain
It has been established that HFD-fed Jnk1/mice exhibit
a severe defect in the development of diet-induced
obesity (Hirosumi et al. 2002). However, selective JNK1
deficiency in adipose tissue, liver, muscle, or myeloid
cells caused no defect in HFD-induced obesity (Sabio
et al. 2008, 2009, 2010). These findings indicate that JNK1
function in another organ accounts for the effects of
whole-body JNK1 deficiency to suppress HFD-induced
weight gain. We therefore tested whether nervous system-
specific JNK1 deficiency might prevent HFD-induced
weight gain. Comparison of chow-fed and HFD-fed NWT
and NKO mice demonstrated that nervous system-specific
JNK1 deficiency markedly reduced weight gain caused by
a HFD (Fig. 1C).
Examination of organ mass at necropsy indicated
a significant reduction in the weight of epididymal white
fat, intrascapular brown fat, quadriceps muscle, and liver
in HFD-fed NKO mice compared with NWT mice (Supple-
mental Fig. S2). In contrast, no significant difference in
heart mass was detected between NKO and NWT mice
(Supplemental Fig. S2). Measurement of lean and fat mass
using 1H-MRS indicated that, while reduced fat accumu-
lation by NKO mice was detected, the NKO mice also
exhibited reduced lean mass compared with NWT mice
(Fig. 2A). These data suggest that the defect in HFD-
induced weight gain observed in NKO mice was due to
a reduction in both fat and lean body mass.
The resistance to weight gain in HFD-fed NKO mice
may account for the finding that HFD-induced JNK
activation in adipose tissue, muscle, and liver of NWT
mice was not detected in NKO mice (Fig. 1D).
JNK1 deficiency increases insulin sensitivity
The hyperglycemia and hyperinsulinemia caused by feed-
ing a HFD to NWTmice was significantly reduced in HFD-
fed NKO mice (Fig. 3A). Similarly, the HFD-induced in-
crease in the blood concentration of adipokines (leptin,
resistin, and IL6) was markedly attenuated in HFD-fed
NKOmice (Fig. 3A; Supplemental Fig. S3). Consistent with
these observations, HFD-fedNKOmice weremore glucose-
tolerant (Fig. 3B), more responsive in an insulin tolerance
test (Fig. 3C), and exhibited increased glucose-induced
insulin release (Fig. 3E) compared with HFD-fed NWT
mice. These data indicate that HFD-fed NKO mice show
increased insulin sensitivity and improved b-cell function
compared with HFD-fed NWT mice. To confirm this
conclusion, we conducted a hyperinsulinemic–euglycemic
Figure 1. Creation of mice with nervous system-specific JNK1
deficiency. (A) Genotype analysis of genomic DNA isolated
from the cortex, cerebellum (Cereb.), hippocampus (Hippo.),
hypothalamus (Hypoth.), and medulla oblongata (M. Oblog.)
of Nes-Cre+ Jnk1+/+ (NWT) mice and Nes-Cre+ Jnk1LoxP/LoxP
(NKO) mice was performed to detect the presence of Jnk1+,
Jnk1LoxP, and Jnk1D alleles. (B) Extracts prepared from the cortex,
cerebellum, liver, muscle (quadriceps), fat (epididymal adipose
tissue), hypothalamus, and hippocampus of NWT and NKO mice
were examined using immunoblot analysis by probing with
antibodies to JNK1 and GAPDH. (C) NWT and NKO male mice
(8–10 wk old) were fed either a chow diet (ND) or a HFD (16 wk).
The weight of the mice was measured (mean 6 SD; n = 10). The
HFD-induced weight gain of NWTwas significantly greater than
NKOmice (P < 0.05). (D) NWTand NKO mice were fed a chow diet
(ND) or a HFD for 16 wk. JNK activity in the liver, quadriceps
muscle, and epididymal adipose tissue wasmeasured in a protein
kinase assay (KA) assay using cJun and [g-32P]ATP as substrates.
The cell extracts used for the protein kinase assay were also
examined by immunoblot analysis by probing with antibodies
to JNK1 and GAPDH.
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clamp study in consciousmice. This analysis demonstrated
significant increases in steady-state glucose infusion rate,
insulin-stimulated whole-body glucose turnover, glycogen
plus lipid synthesis, and hepatic insulin action in HFD-fed
NKO mice compared with HFD-fed NWT mice (Fig. 2A).
These data confirmed that HFD-fed NKO mice are more
insulin-sensitive than HFD-fed NWT mice.
To obtain biochemical evidence for insulin sensitivity,
we examined insulin-stimulated AKT activation in adi-
pose tissue, muscle, and liver of NKO and NWT mice (Fig.
2B). Insulin treatment increased AKTactivation in chow-
fed NKO and NWT mice. Insulin-stimulated AKT activa-
tion was suppressed in adipose tissue, muscle, and liver of
HFD-fed NWT mice, demonstrating insulin resistance in
these organs (Fig. 2B). In contrast, studies of NKO mice
demonstrated that the HFD did not inhibit insulin-
stimulated AKT activation in adipose tissue and muscle,
and only partially suppressed AKTactivation in liver (Fig.
2B). These data strongly support the conclusion that NKO
mice exhibit protection against HFD-induced insulin
resistance. This finding is consistent with the observa-
tion that NKO mice did not gain weight in response to
feeding a HFD (Fig. 1C).
JNK1 deficiency reduces food intake
Metabolic cage analysis demonstrated that HFD-fed NKO
mice consumed slightly less food than HFD-fed NWTmice
(Fig. 4). This decrease in food intake may contribute to
the failure of HFD-fed NKO mice to gain weight. We did
not detect changes in the expression of hypothalamic
neuropeptides that regulate satiety (agouti-related protein
[AgRP], cocaine and amphetamine-regulated transcript
[CART], promelanin-concentrating hormone [PMCH],
and pro-opiomelanocortin [POMC]) that might account
for decreased feeding behavior by HFD-fed NKO mice (Fig.
5A). However, increased leptin signaling might contribute
to the observed reduction in food intake. The adipokine
leptin acts on multiple subsets of neurons in the CNS to
suppress feeding behavior (Myers et al. 2009). The blood
leptin concentration was reduced in HFD-fed NKO mice
comparedwithHFD-fedNWTmice (Fig. 3A). Nevertheless,
Figure 2. Effect of nervous system-specific JNK1 deficiency on insulin sensitivity. (A) Insulin sensitivity was measured using
a hyperinsulinemic–euglycemic clamp in conscious NKO and NWT mice. The steady-state glucose infusion rate (GIR), whole-body
glucose turnover, hepatic insulin action, and whole-body glycogen plus lipid synthesis are presented. Fat and lean body mass were
measured by 1H-MRS. The data presented are the mean 6 SE for six to approximately eight experiments. Statistically significant
differences between NKO mice and NWT mice are indicated ([*] P < 0.05). (B) Chow-fed (ND) and HFD-fed NWT and NKO mice were
treated by intraperitoneal injection of insulin (1.5 U/kg body mass). Extracts prepared from epididymal adipose tissue, quadriceps
muscle, and liver at 15 min post-injection were examined by immunoblot analysis with antibodies to phospho-AKT (Thr-308 and Ser-
473) and AKT. Quantitation was performed using the Odyssey infrared imaging system (LI-COR Biosciences). The data presented are
the mean 6 SD (n = 3). Statistically significant differences between NKO mice and NWT mice are indicated ([*] P < 0.05).
Sabio et al.
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increased hypothalamic leptin signaling in HFD-fed NKO
mice could mediate increased leptin sensitivity. It has
been established that leptin receptor expression is regu-
lated by blood leptin concentration and obesity (Townsend
et al. 2008). Indeed, leptin receptor expression is down-
regulated in HFD-fed mice (Townsend et al. 2008). How-
ever, feeding a HFD did not down-regulate leptin receptor
expression in the hypothalamus ofHFD-fedNKOmice (Fig.
5A). This failure of leptin receptor down-regulation may
contribute to decreased feeding by HFD-fed NKO mice
compared with HFD-fed NWT mice.
JNK1 deficiency increases energy expenditure
We performed metabolic cage analysis of NKO and NWT
mice to determine the effects of nervous system-specific
JNK1 deficiency on energy balance (Fig. 4). No difference
in the respiratory exchange quotient ([VCO2]/[VO2]) be-
tween NKO and NWT mice was detected. However, the
HFD-fed NKO mice exhibited a large increase in physical
activity and energy expenditure compared with HFD-fed
NWT mice (Fig. 4). This effect of JNK1 deficiency to cause
increased energy expenditure and physical activity is
likely to be a major determinant of JNK1-regulated obe-
sity, and may largely account for the failure of HFD-fed
NKO mice to gain weight.
JNK1 deficiency engages the hypothalamic–pituitary–
thyroid axis
We found that NKO mice exhibited elevated body temper-
ature (Fig. 6A) that was associated with a reduction in lipid
accumulation by brown fat and liver in HFD-fed NKOmice
compared with HFD-fed NWT mice (Fig. 6B). Gene expres-
sion analysis demonstrated thatNKOmice expressed larger
amounts of mRNA derived from thyroid hormone target
genes (Supplemental Fig. S5; Obregon 2008). These data
indicate that the thyroid hormone pathway is activated in
NKO mice. Indeed, increased levels of T4 and T3 were
detected in the blood of NKO mice compared with NWT
mice (Fig. 6C). This change was associated with increased
expression of thyrotropin-releasing hormone (Trh) mRNA
in the hypothalamus of chow-fed NKO mice (Fig. 6C),
increased expression of thyroid-stimulating hormone (Tsh)
mRNA in the pituitary gland (Fig. 5B), and increased TSH
protein in the blood of HFD-fed NKO mice (Fig. 6C). TSH
and TRH expression are subject to acute negative feedback
regulation by thyroid hormone (Bjo¨rkman and Ekholm
Figure 3. JNK1 deficiency in the nervous system partially protects mice against the metabolic effects of feeding a HFD. (A) Blood
glucose concentration in chow-fed (ND) and HFD-fed NWT and NKO mice fasted overnight. The blood concentration of insulin, resistin,
and leptin in mice fasted overnight is also presented. The data represent the mean 6 SD (n = 10). Statistically significant differences
between NKO and NWT are indicated ([*] P < 0.05). (B) Glucose tolerance tests (GTT) on chow-fed (ND) and HFD-fed NWT and NKO mice
were performed by measurement of blood glucose concentration in animals following intraperitoneal injection of glucose (1 g/kg). The
data presented represent the mean 6 SD (n = 10;15). Statistically significant differences between NKO and NWT are indicated ([*] P <
0.05). (C,D) Insulin tolerance tests (ITT) on NWT and NKO mice fed either a chow diet (ND) or a HFD were performed by intraperitoneal
injection of insulin (1.5 U/kg body mass). The concentration of blood glucose was measured (mean 6 SD; n = 10). Statistically
significant differences between NKO and NWT are indicated ([***] P < 0.001). (E) Glucose-induced insulin release. The effect of
administration of glucose (2 g/kg body mass) by intraperitoneal injection on blood insulin concentration was examined (mean 6 SD;
n = 13;15). Statistically significant differences between NWT and NKO mice are indicated ([*] P < 0.05).
Regulation of obesity by JNK1
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2000). The presence of high levels of T4 and T3 in the
blood of NKO mice under conditions where TSH and TRH
expression are elevated suggests that brain JNK1 defi-
ciency disrupts the normal negative feedback regulation
of the hypothalamic–pituitary axis.
The effect of JNK1 deficiency on TSH expression sug-
gests that brain-specific JNK1 knockout mice may have
altered pituitary function. Indeed, HFD-fedNKOmicewere
found to have decreased amounts of adrenocorticotropic
hormone (ACTH) and increased amounts of growth hor-
mone (GH) in the blood comparedwithHFD-fedNWTmice
(Supplemental Fig. S4). These data support the conclusion
that JNK1 is required for normal pituitary function.
The hypothalamic–pituitary–thyroid axis contributes
to metabolic regulation by JNK1
To test whether increased thyroid hormone signaling was
causally related to the defect in HFD-induced weight gain
in NKOmice, we examined the effect of treatment of mice
with propylthiouracil (PTU), a drug that inhibits thyro-
peroxidase and prevents T4 production by the thyroid
gland (Bjo¨rkman and Ekholm 2000). We treated NKO and
NWT mice with PTU in the drinking water and examined
the effect of feeding a chow diet or a HFD. Analysis of
intrascapular brown fat demonstrated that PTU treat-
ment suppressed the increased expression of thyroid
hormone-responsive genes in NKO mice (Supplemental
Fig. S5). These data demonstrate that PTU treatment
represents an effective model to study the role of thyroid
hormone signaling in NKO and NWT mice. We found that
the PTU-treated NKO and NWT mice showed similar
increases in body weight when fed a HFD (Fig. 7A;
Supplemental Fig. S6). No significant differences in
glucose, insulin, and adipokine (leptin and resistin) con-
centrations in the blood or body temperature between
PTU-treated NKO and NWT mice were detected (Fig. 7B).
Similarly, no significant differences between PTU-treated
NKO and NWT mice were detected in glucose and insulin
tolerance tests (Fig. 7C). Together, these data demon-
strate that inhibition of thyroid hormone by PTU treat-
ment markedly suppressed the metabolic phenotypes of
NKO mice. This analysis supports the conclusion that
increased thyroid hormone contributes to the metabolic
phenotype of NKO mice.
To test the contribution of thyroid hormone to the
phenotype of whole-body JNK1 knockout mice, we
examined the effect of PTU treatment on Jnk1/ mice.
We found that PTU treatment significantly suppressed
the effect of whole-body JNK1 deficiency on HFD-
induced weight gain, hyperglycemia, glucose intolerance,
insulin sensitivity, and glucose-induced insulin release
(Supplemental Figs. S7, S8). However, the PTU treatment
caused greater suppression of the metabolic phenotype of
NKO mice than Jnk1/ mice, consistent with metabolic
roles of JNK1 in both neuronal and nonneuronal tissues.
Discussion
The mechanism of obesity-induced insulin resistance,
metabolic syndrome, and type 2 diabetes may involve
the JNK1 signaling pathway. Thus, mouse studies have
demonstrated that treatment with JNK inhibitors can
reduce hyperglycemia and improve insulin sensitivity
(Bennett et al. 2003; Kaneto et al. 2004; Stebbins et al.
2008). Moreover, Jnk1/ mice are protected against the
development of HFD-induced obesity and insulin resis-
tance (Hirosumi et al. 2002). Analysis of tissue-specific
JNK1 knockout mice demonstrates that JNK1 deficiency
in adipose tissue, muscle, liver, or myeloid cells does not
prevent HFD-induced weight gain (Sabio et al. 2008, 2009,
2010). Nevertheless, adipose tissue-specific NKO mice do
exhibit defects in HFD-induced insulin resistance in
adipose tissue and liver (Sabio et al. 2008). Moreover,
muscle-specific NKO mice are protected against HFD-
induced muscle insulin resistance (Sabio et al. 2010).
These observations demonstrate that JNK1 can regulate
insulin resistance independently of the effects of JNK1 on
HFD-induced weight gain. In addition, this analysis estab-
lished that JNK1-regulated insulin resistance involves
more than one mechanism, including JNK1-regulated
expression of inflammatory cytokines (Sabio et al. 2008),
Figure 4. Comparison of energy balance of NWT and NKO mice
using metabolic cages. Mice were examined during a 3-d period
to measure the food and water consumption, gas exchange (VO2
and VCO2), respiratory exchange quotient [VCO2]/[VO2 ], energy
expenditure, and physical activity (mean 6 SE, n = 6). Statisti-
cally significant differences between NKO mice and NWT mice
are indicated ([*] P < 0.05; [**] P < 0.01; [***] P < 0.001).
Sabio et al.
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JNK1-regulated expression of lipoprotein lipase (Sabio
et al. 2010), and JNK1-mediated negative regulatory phos-
phorylation of the insulin receptor adapter protein IRS1
(Aguirre et al. 2000; Hirosumi et al. 2002; Lee et al. 2003;
Sabio et al. 2008, 2010).
JNK1 deficiency in the nervous system is sufficient to
protect mice against weight gain caused by feeding a
HFD. The weight gain of NWT mice is mediated, in part,
by reduced physical activity and energy expenditure. In
contrast, feeding a HFD to mice with JNK1 deficiency in
the nervous system (NKO mice) does not cause decreased
physical activity and energy expenditure. This main-
tenance of physical activity and energy expenditure in
HFD-fed NKO mice contributes to the failure of these
mice to gain weight when fed a HFD.
The increased energy expenditure in NKO mice is
mediated, in part, by activation of the hypothalamic–
pituitary–thyroid axis. This conclusion is based on sev-
eral lines of evidence, including increased body temper-
ature, increased expression of thyroid hormone-induced
genes, and increased amounts of T4 and T3 in the blood of
NKO mice compared with NWT mice. Moreover, pharma-
cological inhibition of thyroid hormone production abol-
ished the metabolic phenotypes of NKO mice, including
marked suppression of HFD-induced weight gain. These
data identify the hypothalamic–pituitary–thyroid axis as
an important target of the metabolic actions of JNK1.
The thyroid hormone pathway is negatively regulated
by JNK1. The increased amount of T4 and T3 in the blood
of NKO mice compared with NWT mice correlates with
increased expression of hypothalamic TRH and pituitary
gland TSH. These changes in TRH and TSH expression
were unexpected because thyroid hormone exerts power-
ful negative feedback control of TRH and TSH expression
(Bjo¨rkman and Ekholm 2000). The association of in-
creased T4 and T3 in the blood with increased expression
of TRH and TSH in NKO mice indicates that JNK1
deficiency in the brain disrupts the normal negative
feedback control of the hypothalamic–pituitary–thyroid
axis. An important goal for future studies will be to
determine the molecular mechanism of JNK1 regulation
of the hypothalamic–pituitary–thyroid axis.
In conclusion, this study demonstrates that JNK1 de-
ficiency in the nervous system is sufficient to account for
the role of JNK1 in the regulation of HFD-induced weight
gain. This knowledge has important implications for the
design of novel therapeutic interventions in the treat-
ment of diet-induced obesity.
Materials and methods
Mice
We previously described Jnk1/ mice (Dong et al. 1998) and
Jnk1LoxP/LoxPmice (Das et al. 2007).Nes-Cremice (Tronche et al.
Figure 5. Gene expression in the hypothalamus and
pituitary gland of NWT and NKO mice. (A) NWT and NKO
mice were fed a chow diet (ND) or a HFD (16 wk) and
then fasted overnight. The expression of AgRP, leptin re-
ceptor, somatostatin, gonadotrophin-releasing hormone
(GnRH), PMCH, POMC, CART, and GH-releasing
hormone (GHRH) mRNA in the hypothalamus was
measured by quantitative RT–PCR. The data were
normalized to the expression of Gapdh mRNA in each
sample. The data are presented as the mean6 SD (n = 6).
Statistically significant differences between NWT and
NKO mice are indicated ([*] P < 0.05). (B) The expression
of TSHb, GH, and POMC mRNA in the pituitary gland
was measured by quantitative RT–PCR. The data were
normalized to the expression of Gapdh mRNA in each
sample. The data are presented as the mean6 SD (n = 6).
Statistically significant differences between NWT and
NKO mice are indicated ([*] P < 0.05; [**] P < 0.01).
Regulation of obesity by JNK1
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1999) were obtained from The Jackson Laboratories, and Rip-
CreESR mice (Dor et al. 2004) were obtained from D. Melton
(Harvard University). The mice were backcrossed to the C57BL/
6J strain (The Jackson Laboratories) and were housed in facilities
accredited by the American Association for Laboratory Animal
Care (AALAC). The mice were genotyped by PCR analysis of
genomic DNA (Das et al. 2007). All studies were performed using
male mice (8–24 wk old). The mice were treated with PTU in the
drinking water (cherry-flavored Kool-Aid supplemented without
or with 1.2 mM PTU [Sigma]). Body temperature was measured
using a Microtherma 2 Type ‘‘T’’ Thermometer (Braintree
Scientific, Inc.). Rip-CreESR mice were treated with 1 mg of
4-hydroxytamoxifen (Sigma) by intraperitoneal injection once each
day for five consecutive days. The animal studies were approved
by the Institutional Animal Care and Use Committees of the
University of Massachusetts Medical School and the Pennsylva-
nia State University College of Medicine.
RNA analysis
The expression of mRNA was examined by quantitative PCR
analysis using a 7500 Fast Real-Time PCR machine. TaqMan as-
says were used to quantitate Accb (Mm01204683_m1), Agrp
(Mm00475829_g1),Cart (Mm00489086_m1),Ghrh (Mm01250745_
m1), Gnrh (Mm01315605_m1), Gh (Mm00433590-g1), Glut4
(Mm00436615-m1), Ldhb (Mm00493146_m1), Leptin receptor
(Mm00434759_m1), Pck1 (Mm00440636_m1), Pmch (Mm242886_
g1), Pomc (Mm00599949_m), Somatostatin (Mm 00436671_m1),
Spot14 (Mm01273967_m1), Trh (Mm01963590_s1), Tshb
(Mm00437190_m1), and Ucp1 (Mm01244861-m1). The relative
mRNA expression was normalized by measurement of the
amount of Gapdh mRNA (#4352339E) in each sample using
TaqMan assays (Applied Biosystems).
Isolation of pancreatic islets
Murine pancreatic islets were isolated using methods described
previously (Mangada et al. 2009).
Immunoblot analysis
Tissue extracts were prepared using Triton lysis buffer (20 mM
Tris at pH 7.4, 1% Triton X-100, 10% glycerol, 137 mM NaCl,
2mMEDTA, 25mMb-glycerophosphate, 1mMsodiumorthova-
nadate, 1 mM phenylmethylsulfonyl fluoride, 10 mg/mL of
aprotinin and leupeptin). Extracts (20–50 mg of protein) were
examined by protein immunoblot analysis by probing with
antibodies to AKT, phospho-Thr308 AKT, and phospho-Ser473
AKT (Cell Signaling); and JNK1 and GAPDH (Santa Cruz Bio-
technologies). Immunocomplexes were detected by enhanced
chemiluminescence (NEN). Quantitation of immunoblots was
performed using the Odyssey infrared imaging system (LI-COR
Biosciences).
Measurement of blood glucose, adipokine, cytokine, and
insulin concentration
Blood glucose was measured with an Ascensia Breeze 2 gluco-
meter (Bayer). Adipokines, cytokines, and insulin in plasma
were measured by ELISA using a Luminex 200 machine (Milli-
pore).
Glucose and insulin tolerance tests
The mice were fed a standard chow diet or a HFD (Iso Pro 3000,
Purina; and F3282, Bioserve, Inc.) for 16 wk. Glucose and insulin
tolerance tests were performed using methods described pre-
viously (Mora et al. 2005).
Protein kinase assays
JNK activity was measured using an in vitro protein kinase assay
with the substrates cJun and [g-32P]ATP as substrates (Whitmarsh
and Davis 2001).
Hyperinsulinemic–euglycemic clamp studies
The clamp studies were performed at the University of Massa-
chusetts Mouse Phenotyping Center. Briefly, mice were fed
a HFD diet (55% fat by calories; Harlan Teklad) or chow diet
Figure 6. Activation of the hypothalamic–pituitary–thyroid
hormone axis in NKO mice. (A) The body temperature of
chow-fed (ND) and HFD-fed NKO and NWT mice are presented
(mean 6 SD; n = 8). Statistically significant differences between
NKO and NWT mice are indicated ([*] P < 0.05). (B) Sections
prepared from intrascapular brown fat and liver of chow-fed
(ND) and HFD-fed NKO and NWT mice were stained with
hematoxylin and eosin. Bar, 100 mm. (C) The concentration of
T3, T4, and TSH in the blood of chow-fed (ND) and HFD-fed
NKO and NWT mice was measured by ELISA (mean 6 SD, n =
10). The amount of Trh mRNA in the hypothalamus was mea-
sured by quantitative RT–PCR analysis and was normalized to
the amount of GapdhmRNAmeasured in each sample (mean 6
SD; n = 6;7). Statistically significant differences between NKO
and NWT mice are indicated ([*] P < 0.05; [**] P < 0.01).
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for 3 wk, and whole-body fat and lean mass were noninvasively
measured using 1H-MRS (Echo Medical Systems). Following an
overnight fast, a 2-h hyperinsulinemic–euglycemic clamp was
conducted in conscious mice with a primed and continuous
infusion of human insulin (150 mU/kg body weight priming
followed by 2.5 mU/kg/min; Humulin; Eli Lilly), and 20%
glucose was infused at variable rates to maintain euglycemia
(Kim et al. 2004). Whole-body glucose turnover was assessed
with a continuous infusion of [3-3H]glucose, and 2-deoxy-D-
[1-14C]glucose (PerkinElmer) was administered as a bolus (10
mCi) at 75 min after the start of the clamps to measure insulin-
stimulated glucose uptake in individual organs. At the end of the
clamps, mice were anesthetized, and tissues were taken for
biochemical analysis (Kim et al. 2004).
Metabolic cages
Mice were housed under controlled temperature and lighting
with free access to food and water. The food/water intake, energy
expenditure, respiratory exchange ratio, and physical activity
were performed (3 d) using metabolic cages (TSE Systems).
Analysis of tissue sections
Histology was performed using tissue fixed in 10% formalin for
24 h, dehydrated, and embedded in paraffin. Sections (7 mm) were
cut and stained using hematoxylin and eosin (American Master
Tech Scientific).
Statistical analysis
Differences between groups were examined for statistical signif-
icance using the Student’s test or analysis of variance (ANOVA)
with the Fisher’s test.
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Figure 7. Disruption of thyroid hormone signaling
prevents the effects of nervous system-specific JNK1
deficiency on HFD-induced weight gain. (A) NKO and
NWT mice were treated with PTU in the drinking
water. The mice were divided into chow-fed (ND)
and HFD-fed groups after 2 wk, and then maintained
for an additional 10 wk. The body weight of the mice
is presented. No statistically significant differences
between NKO and NWT mice were detected (P > 0.05).
(B) Chow-fed (ND) and HFD-fed NKO and NWT mice
were examined after 12 wk of treatment with PTU.
The blood glucose concentration in fed and overnight
fasted mice, body temperature, and the blood hor-
mone (insulin, leptin, and resistin) concentrations
are presented. No significant differences between
NKO and NWT mice were detected (P > 0.05). (C)
Glucose tolerance tests (GTT) on PTU-treated chow-
fed (ND) and HFD-fed NKO and NWT mice are pre-
sented. No significant differences between NKO and
NWT mice were detected (P > 0.05). Insulin tolerance
tests (ITT) on PTU-treated HFD-fed NKO and NWT
mice are presented. No significant differences be-
tween NKO and NWT mice were detected (P > 0.05).
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